Cargando…
Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population
INTRODUCTION: High on-treatment platelet reactivity (HTPR) to clopidogrel imparts an increased risk for ischemic events in adults with coronary artery disease. Platelet reactivity varies with ethnicity and is influenced by both clinical and genetic variables; however, no clopidogrel pharmacogenetic...
Autores principales: | Hernandez-Suarez, Dagmar F, Botton, Mariana R, Scott, Stuart A, Tomey, Matthew I, Garcia, Mario J, Wiley, Jose, Villablanca, Pedro A, Melin, Kyle, Lopez-Candales, Angel, Renta, Jessicca Y, Duconge, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996853/ https://www.ncbi.nlm.nih.gov/pubmed/29922082 http://dx.doi.org/10.2147/PGPM.S165805 |
Ejemplares similares
-
2042 CYP2C19*2 and PON1 Q192R polymorphisms are associated with platelet reactivity to clopidogrel in Puerto Rican Hispanics with cardiovascular disease
por: Suarez, Dagmar F. H., et al.
Publicado: (2018) -
2529: Clinical determinants of clopidogrel responsiveness in a heterogeneous cohort of Caribbean Hispanics
por: Suarez, Dagmar Fredy Hernandez, et al.
Publicado: (2018) -
Discovery of Ancestry-specific Variants Associated with Clopidogrel Response among Caribbean Hispanics
por: Yang, Guang, et al.
Publicado: (2023) -
2220: Pharmacogenomic determinants in Caribbean Hispanics of clopidogrel failure in acute coronary syndrome
por: Melin, Kyle, et al.
Publicado: (2018) -
Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach
por: Duconge, Jorge, et al.
Publicado: (2021)